Showing results (161-170 of 176) with videos related to
Sort By:
Pageof 18
Cancer Discovery|May 11, 2022
Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non-Small Cell Lung CancerJia-Tao Zhang, Si-Yang Liu, Wei Gao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 19, 2023
Allelic Context of EGFR C797X-Mutant Lung Cancer Defines Four Subtypes With Heterogeneous Genomic Landscape and Distinct Clinical OutcomesChang Lu, Xue-Wu Wei, Zhen Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 10, 2025
First-Line Camrelizumab Versus Placebo Plus Chemotherapy With or Without Radiotherapy for Brain Metastases in NSCLC: The CTONG 2003 Randomized Placebo-Controlled TrialYang-Si Li, Qitao Yu, Qing Bu, et al.JAMA Oncology|June 13, 2024
Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSong Dong, Zhen Wang, Jia-Tao Zhang, et al.Eclinicalmedicine|October 2, 2023
Efficacy, safety and dose selection of AZD3759 in patients with untreated EGFR-mutated non-small-cell lung cancer and central nervous system metastases in China (CTONG1702-Arm 8): a multi-center, single-arm, phase 2 trialSi-Yang Maggie Liu, Xiao-Rong Dong, Zhen Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2020
Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III TrialWen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2025
Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON StudyJin-Ji Yang, Yu Mu, Zhe-Hai Wang, et al.Cancer Cell|October 10, 2023
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patientsYi Pan, Jia-Tao Zhang, Xuan Gao, et al.Cell Reports|August 8, 2024
Lipid-associated macrophages for osimertinib resistance and leptomeningeal metastases in NSCLCYang-Si Li, Wen-Pu Lai, Kai Yin, et al.Nature Medicine|July 24, 2023
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trialSi-Yang Maggie Liu, Hai-Yan Tu, Xue-Wu Wei, et al.Pageof 18